5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Epigral Ltd.

•
epigral.comBSE: 543332NSE: EPIGRAL
Market Cap₹ 5,350 Cr.
Current Price
High / Low₹ 1,815 / 807
Stock P/E19.7
Book Value₹ 538
Price to Book1.57
Dividend Yield0.40 %
ROCE15.7 %
ROE16.1 %
Face Value₹ 10

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2011 • Caustic: 100.0%

AI Sector View

AI GENERATED

Chemicals

Hold

The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.

Confidence
55%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 27.0% CAGR over last 5 years
  • Company has delivered good sales growth of 25.0% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.44x)
  • Working capital cycle has improved - days down from 38 to 16
  • Company generates healthy free cash flow
  • Company maintains a comfortable, low leverage position

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Recent results are weak - TTM profit is down 45.0% versus prior year
  • Promoter holding has decreased over last 2 years: -2.8pp
  • Operating margins have contracted to 21.2% from 30.1%
  • Growth is decelerating - 3Y profit CAGR (-2.0%) trails the 5Y trend (27.0%)
  • Though reporting repeated profits, the company pays out little dividend (6.5%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

ChemicalsChemicalsChemicals
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SOLARINDS21410.7097.29193745.540.05666.3788.983668.2070.2638.1627.91
2.PIDILITIND1632.0062.71166117.971.328835.101202.8645515.501112.7432.3826.28
3.SRF2605.0035.7277218.670.35758.8775.535033.2634.6314.2124.57
4.FLUOROCHEM4691.6083.8051537.230.06219.0019.021588.0023.979.5826.83
5.NAVINFLUOR8697.2056.5144623.690.17243.31107.671045.0844.0721.3934.17
6.GODREJIND1155.9033.1238936.610.00523.36-27.855448.0922.1610.6412.82
7.DEEPAKNTR1727.2530.0823558.490.43345.01207.362577.6036.3911.5820.96
8.AETHER1656.3593.4721984.380.0062.7533.45326.5627.4911.6531.47
9.ATUL6465.5023.9319035.570.46253.9391.851847.9525.0315.0521.41
10.AARTIIND501.7534.2718199.810.20155.00260.472387.0042.426.9516.00
11.DEEPAKFERT1356.3017.4617179.290.74490.04100.953256.2622.4712.1225.96
12.EPIGRAL1240.0519.745349.740.4099.74-37.93705.3616.2915.6525.48
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
455478472525651626645628607587597736705
360370349369475448463454443455494568576
Operating Profit95108123155176178183173163132103169129
OPM %20.93%22.56%26.04%29.62%27.09%28.50%28.29%27.62%26.94%22.53%17.21%22.90%18.30%
21222643826-14
Interest182120141427-012232211167
Depreciation31323130333233344242434243
Profit before Tax4856741131311241541311077055111133
Tax %33.42%32.01%33.51%32.06%34.39%35.27%32.56%33.91%-50.30%26.35%28.30%25.87%25.53%
Net Profit3238497786811048716052398299
7.629.1811.8718.4520.7019.3824.2320.0837.1811.949.0818.9922.99

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
3925987106118291,5512,1881,9292,5502,5272,626
2473423994165671,0411,4991,4481,8391,9602,093
Operating Profit144255312194261509689481711567533
OPM %36.79%42.72%43.87%31.80%31.54%32.85%31.48%24.94%27.87%22.44%20.29%
141497897151511
Interest149301734486773537256
Depreciation555554447486109124133168170
Profit before Tax75195242141161383523291540342368
Tax %11.34%20.34%24.55%20.56%37.31%34.07%32.38%32.64%33.96%2.57%26.20%
Net Profit67155183112101253353196357333272
EPS9.4021.9725.0919.1717.2660.8485.0447.1282.6877.19—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%5.88%10.61%7.26%6.48%—

COMPOUNDED SALES GROWTH

10 Years:
20%
5 Years:
25%
3 Years:
5%

COMPOUNDED PROFIT GROWTH

10 Years:
17%
5 Years:
27%
3 Years:
-2%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
-31%

RETURN ON EQUITY

10 Years:
30%
5 Years:
27%
3 Years:
19%
Last Year:
16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Jun 1

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

2025

Jun 20

₹ 0.35

Rs.3.5000 per share(35%)Final Dividend

2025

Feb 7

₹ 0.25

Rs.2.5000 per share(25%)Interim Dividend

2024

Jul 2

₹ 0.50

Rs.5.0000 per share(50%)Final Dividend

2023

Jun 20

₹ 0.25

Rs.2.5000 per share(25%)Final Dividend

2023

Feb 1

₹ 0.25

Rs.2.5000 per share(25%)Interim Dividend

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
71714142424242424343
2914472413314326841,0281,2131,8602,178
6034376443419851878768505466
Trade Payables183336477388110184186260
8279350410483459374588557559
Total Liabilities5226631,0441,2731,4492,1242,4322,7943,1513,505
3983472954401,1021,0681,8041,7672,2382,117
Capital Work in Progress37946869112658915848364451
2971000021219723
2830414854154212263388349
0000000179232417
Cash & Bank051290125157225
651311119316628722376110144
Total Assets5226631,0441,2731,4492,1242,4322,7943,1513,505

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
158263320193258344734398441436
Cash from Investing-63-167-217-363-197-455-437-401-262-355
Cash from Financing-76-588569-32195-200-8-164-94
-0-0129-129124-11-1115-14

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
PER SHARE
EPS (₹)9.4021.9744.3826.9524.2760.8485.0447.1282.6877.19
Book Value (₹)51.1273.1168.4289.66113.88174.72257.32301.83441.24514.94
Dividend per Share (₹)0.000.000.000.000.000.005.005.006.005.00
Cash EPS (₹)17.2429.7857.5137.6141.9781.51111.2776.86113.41116.20
PROFITABILITY
Operating Margin %32.63%42.19%44.98%31.90%31.37%32.26%30.13%24.01%26.39%21.23%
Net Margin %14.98%25.28%25.23%17.63%11.77%15.75%15.24%9.77%13.25%12.46%
ROE %20.26%35.37%45.75%34.23%23.85%42.16%39.37%16.85%22.59%16.15%
ROCE %18.45%37.92%36.88%15.90%16.74%29.40%32.20%17.50%25.22%15.69%
12.53%26.23%21.42%9.67%7.41%14.15%15.51%7.49%12.00%10.01%
EFFICIENCY
Debtor Days37363944424333312844
Inventory Days27171826222429434450
Payable Days48395055573932515057
161471572830242238
FINANCIAL HEALTH
Debt to Equity (x)0.34x0.14x0.79x0.90x0.79x1.36x0.82x0.77x0.31x0.25x
Interest Coverage (x)6.19x22.76x9.20x9.11x5.68x8.91x8.82x4.96x11.14x5.75x
0.92x1.23x1.44x0.50x0.47x0.84x0.65x0.64x1.56x1.16x
GROWTH
Revenue Growth %-1.66%52.60%18.89%-14.06%35.72%87.18%41.10%-11.84%32.19%-0.90%
Operating Profit Growth %-3.78%78.99%25.65%-37.82%32.63%92.64%34.85%-30.16%48.84%-19.82%
Net Profit Growth %-0.96%133.66%17.58%-38.73%-9.96%150.68%39.78%-44.59%82.19%-6.64%
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-44.59%75.47%-6.64%
VALUATION
P/E (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x23.26x22.96x10.49x
P/B (x)0.00x0.00x0.00x0.00x0.00x0.00x0.00x3.63x4.30x1.57x
Dividend Yield %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.46%0.32%0.62%
0.00x0.00x0.00x0.00x0.00x0.00x0.00x11.30x12.06x6.96x

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
71.5871.5868.9468.9568.8368.8368.8368.8368.83
1.462.103.013.013.062.712.361.541.03
0.181.174.314.664.784.925.134.905.56
0.020.020.020.020.020.020.020.020.02
26.7425.1323.7223.3523.3123.5223.6624.7024.55

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-08-31
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-31 - Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.2026

2026-08-18
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-18 - Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026

2026-08-07
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-07 - Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on Monday, 3rd August, 2026.

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Epigral Limited has informed the Exchange about Transcript

2026-07-29
Copy of Newspaper Publication

2026-07-29 - Epigral Limited has informed the Exchange about Copy of Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026

2026-07-27
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-27 - Epigral Limited has informed the Exchange about Link of Recording

2026-07-27
Investor Presentation

2026-07-27 - Epigral Limited has informed the Exchange about Investor Presentation

2026-07-27
Press Release

2026-07-27 - Epigral Limited has informed the Exchange regarding a press release dated July 27, 2026, titled "Press Release on Un-Audited Financial Results Q1 FY27".

News

Recent coverage and analyst commentary for EPIGRAL

Loading news…

🤖

AI Stock Analyst

Epigral Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login